Mobile

An Interventional, Single-site, Open-label, Four-group, Single-dose Study Investigating the Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment (Mild, Moderate, or Severe) and in...

Update Il y a 4 ans
Reference: DRKS00006361

An Interventional, Single-site, Open-label, Four-group, Single-dose Study Investigating the Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment (Mild, Moderate, or Severe) and in Healthy Subjects

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Inclusion criteria

  • N18 - Chronic kidney disease,Renal Impairment

Links